- Investing Ideas
- South Korean Healthcare Undervalued based on future growth
South Korean Healthcare Undervalued based on future growth
Results
7
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
7 companies
T&L
Market Cap: ₩505.9b
Engages in the manufacture and sale of medical and polymer material products in South Korea.
A340570
₩63,100.00
7D
3.3%
1Y
-12.2%
InBodyLtd
Market Cap: ₩403.5b
Provides body composition analysis solutions worldwide.
A041830
₩30,250.00
7D
2.5%
1Y
25.0%
Value Added Technology
Market Cap: ₩347.6b
Manufactures and sells dental medical X-ray devices in Korea, Asia, Australia, Europe, North and South America, and the Middle East.
A043150
₩23,400.00
7D
1.5%
1Y
15.3%
Dentium
Market Cap: ₩334.3b
Manufactures and sells dental medical instrument worldwide.
A145720
₩54,100.00
7D
1.1%
1Y
-25.9%
Interojo
Market Cap: ₩254.0b
Manufactures and sells contact lenses in South Korea and internationally.
A119610
₩22,250.00
7D
10.1%
1Y
n/a
Vieworks
Market Cap: ₩239.5b
Develops, manufactures, and sells imaging systems and solutions.
A100120
₩27,900.00
7D
0.9%
1Y
13.6%
Meta Biomed
Market Cap: ₩119.1b
Engages in the research, development, and production of dental and surgical materials in South Korea, Asia, Europe, the United States, and Africa.
A059210
₩4,555.00
7D
1.3%
1Y
-1.0%